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Antiserum raised in  one species against  lymphoid cells of another  (beter- 
ologons  antilymphocyte  serum,  ALS)  exerts  powerful  immunosuppressive 
effects when injected into members of the lymphoid donor species (8, 20, 34). 
Despite intensive investigation there is yet no clear agreement concerning the 
mechanism of this immtmosuppression. Various possibilities have been sum- 
maxized by Levey and Medawar  (20). 
All workers are agreed that the administration  of ALS causes widespread 
changes in lymphoid tissues; however, the type and magnitude of the changes 
reported  have  been variable  and  often  conflicting.  Some  studies  have  em- 
phasized generalized lymphoid depletion following ALS treatment (8, 25) while 
others have noted discrete lymphoid tissue lesions (27, 31) or lymphoid hyper- 
plasia (2, 12, 20). Similarly, the correlation between the degree of immunosup- 
pression and lymphopenia obtained by some workers  (8)  was  not noted by 
others (14). The determination of the histologic features that are invariably 
linked with immunosuppression by ALS would be helpful in clarifying its mode 
of action. 
Toxic effects of ALS have been noted, particularly on red blood cells and on 
glomerular capillaries (10, 12,  16).  It would be helpful to learn whether  these 
effects are due to antibodies irrelevant to the immunosuppressive  activity of 
ALS.  It  would  also  be  important  to  characterize other possible  toxic  con- 
sequences of ALS and the relation of their pathogenesis to the desired immuno- 
suppressive effects. 
Materials and Methods 
M/ce.--CBA mice of either sex, between 2 and 4 months old, obtained from the breeding 
unit of the National Institute  for Medical Research, were used throughout these studies. 
P~'epavatlon amt Assay of ALS.--Antilymphocytic serum for routine use was prepared by 
the method of Levey and Medawar (20). Adult New Zealand rabbits were given two intra- 
venous injections  of 10  ° CBA thymocytes a fortnight apart, and bled 1 wk after the last injec- 
tion. The serum was heated to 56°C for 30 mln; sterilized by Seitz filtration, and stored at 
--20°C until use. Normal rabbit serum (NRS) was obtained from unimmunized  NZ rabbits 
and processed  in an identical manner. 
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Several antisera were prepared  by incorporating adjuvants into the cell suspension and 
imm,mlzing the rabbits  by intramuscular inoculation. Adjuvants used included alumininm 
phosphate, and Arquad-2-HT (dioctadecyl dimethylammoninm chloride). Various other anti- 
sera were also examined with respect to the histological changes evoked in the lymph nodes of 
recipients.  These  included:  (a)  horse-anti-mouse  lymphocyte  globulin  (HALGG)--batch 
4096A supplied for these experiments by Dr. David Long of the WeIIcome Foundation;  (b) 
duck-anti-mouse lymphocyte serum (DAMLS)--this was antiserum  prepared  in ducks  in a 
manner similar to that used in rabbits  (15). 
The 7S IgG fraction of ALS was isolated by ammonium sulfate precipitation, and column 
chromatography using either Sephadex G-150  or DEAE cellulose,  by standard  techniques. 
Some antisera were absorbed  overnight at 4°C with 4:1  (v/v) of washed  packed  CBA 
erythrocytes before use. 
Immunosuppressive potency of various antisera was assayed by their ability to prolong the 
survival of female A strain tail skin transplanted to CBA mice. Routine antiserum  (0.S ml), 
given subcutaneously on day +2 and day +5 for a total dose of 1.0 ml, regularly prolonged the 
mean survival time  CMST) from 11.3 4- 0.d days to more than 20 days. The "adjuvant" 
antisera were at least as effective as routine antisera. The HALGG was somewhat less effective 
(MST, 18.0 days); the duck antiserum was totally ineffective. 
Stqn Grafls.--Grafts of tail skin from A strain mice to the right flank of CBA mice were 
performed according to the technique of Billingham and Medawar (3). 
Administration  of A/_~.--The effects of antiserum administred in the following regimens 
were studied: 
1.  Rougine antiserum, single dose: Parallel groups of mice were injected subcutaneously with 
a singie 0.5 ml dose of either ALS or N'RS, in the right axillary region, and sacrificed  three at a 
time on days 1, 2, 4, 7, 10, 14, and 21 after injection. 
2. Routine antiserum, short course: Groups of mice were given three doses of 0.5 ml ALS or 
NRS subcutaneously at 2-day intervals, and sacrificed  1, 2, 4, 7, 14, and 21 days after the last 
dose. 
3. Routine antiserum, chronic treament:  Groups of mice were given an initial loading dose of 
three closely spaced injections of whole unabsorbed ALS followed by weekly maintenance doses 
of either 0.25 ml or 0.5 ml. Control animals received weekly injections of NRS. This regimen 
was continued for as long as 6 months. Mice were sacrificed in pairs from each group at various 
intervals, or, if death occured, were autopsied on that day. 
4. Purified IgG fraction of ALS, single dose: Groups of mice were given 5 mg of the purified 
IgG fraction of ALS subcutaneously and sacrificed two at a time, 1, 2, 4, and 5 days after injec- 
tion. Some groups of mice were given a paralyzing dose of 200#g NRS IgG (19) 3 wk before the 
ALS IgG dose. 
5.  Adju~ant antisera: Groups of recipients were given one or two doses of 0.5 ml of whole 
unabsorbed antiserum 3 days apart, and sacrificed  at 1, 2, and 3 wk after injection. 
6.  Miscellaneous antisera: Groups of recipients were given a singie dose of 0.5 ml of whole 
unabsorbed antiserum, and sacrificed  at 1, 2, 4, 6, and  10 days after injection. 
7.  High dose intravenous ALS: Recipients were given intravenous injections of either 0.5 ml 
or 1.0 ml ALS or NRS via the tail vein over a  period of 3-5 rain. Animals were sacrificed 
1, 2, and 4 days after injection. 
ttema~ologic and Morphologic St~dies.--Mice were bled from the tail artery or by cardiac 
puncture under ether anesthesia; the capillary microhematocrit, total leukocyte count, and 
Wright-stained differential leukocyte count were performed by routine methods. Blood smears 
were scanned visually for gross changes in platelet numbers or morphology. 
Histology.--Mice were sacrificed  by cervical dislocation and  the peripheral lymph nodes 
(brachial, axillary, inguinal), mesenteric nodes, Peyer's patch, spleen,  liver, kidney, adrenal, 
thymus, sternal bone marrow, lung, heart, skeletal musele, brain, and grafted skin were fixed 
in  10%  neutral  formalin  for  histological  processing.  Sections  were  stained  with  either ROBERT  N. TAUB AND EUGENE  M. LANCE  1283 
hematoxylin and eosin  or  methyl green-pyronine.  Smears of  lymph nodes  and femoral  bone 
marrow were also taken and stained with Wright's stain. 
OBSERVATIONS 
Effects  of a Single Subcutaneous  Dose of ALS or NRS.-- 
Hematologic changes: Anemia was a constant feature in animals given a single 
dose of unabsorbed ALS; a fall in  hematocrit of 10% or more was observed 
within 48 hr after injection and persisted for 1 wk or longer.  Prior absorption 
of the antiserum with mouse erythrocytes ameliorated or abolished the anemia. 
A  marked  drop  in  both  circulating  granulocytes  and  lymphocytes  was 
observed within 6 hr of injection. Absolute lymphocyte levels remained pro- 
foundiy depressed to 10-20 % of normal for 48 hr,  and continued to remain 
somewhat below normal levels for 2 wk or longer (Fig. 1 a). Antiserum absorbed 
with mouse red cells retained the ability to induce lymphopeula. 
Anemia or lymphopenia were not seen 2 days after a  single  dose of normal 
rabbit serum; rather, a distinct lymphocytosis was seen on the 6th  day postin- 
jection. 
Abundant platelets were present in peripheral blood smears taken from both 
ALS and  NRS-treated  animals.  An  abnormal  bleeding tendency was never 
observed in this group. 
Lymph nodes: Within the first 48 hr after ALS injection, focal accumulations 
of cellular  debris and pyknotic nuclei could be detected in the small vessels of 
the loose cortex or paracortical regions  of lymph nodes draining the injection 
site (right axillary), as well as more distant lymph nodes (Fig. 7). 
By 48 hr a striking depletion of small lymphocytes was noted in both ipsi- 
and contralateral axillary, brachial, and inguinal nodes, and to a lesser extent in 
mesenteric nodes; this depletion was sharply confined to the paracortical region. 
A few small lymphocytes remained, closely associated with postcapillary yen- 
tiles, but the contents of this region consisted for the most part of reticulum 
cells, large lymphocytes, and immunoblasts (Fig. 3). 
By 96 hr, lymphocytes began to reappear in this area, but significant  deple- 
tion remained for 1 wk or longer after some antisera.  By this time,  also, in- 
creased numbers of immunoblasts and reticulum  cells could be seen in the cortex 
and paracortical area. Moreover, a pronounced medullary hyperplasia with the 
production of plasma cell precursors was in evidence. 
Between 4 and 10 days after injection, the medullary hyperplasia increased, 
and plasma cells appeared in large numbers within medullary sinusoids.  Ger- 
minal follicles appeared in some axillary nodes (Fig. 5). 
Animals treated with a single dose of normal rabbit serum showed no lympho- 
cyte depletion. Between 4 and 10 days after injection, medullary hypertrophy, 
germinal center formation, and plasmacytosis were noted. These changes were 
slightly less intense than in ALS-treated animals (Figs. 4 and 6). 
In both ALS- and NRS-treated animals,  the weight of peripheral (axillary) | 
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lymph nodes increased for 6 days after injection, and approached  normal  by 
10 days  (Fig.  lb). 
Spleen: By 48 hr after a single dose of ALS, there was usually a slight increase 
in spleen weight due to hyperplasia of the red pulp with increased myeloid and 
erythroid  precursor  cells.  This  hyperplasia  could  be  lessened  but  was  not 
abolished by prior absorption of the antiserum with mouse red cells. 
By 96 hr after injection, occasional  follicles showed mild depletion of small 
lymphocytes from periarteriolar  areas; this was neither striking nor uniform. 
NRS-treated  animals  showed neither  increased  splenic  erythropoiesis nor 
lymphoid depletion. 
In both ALS- and NRS-treated animals,  a moderate follicular hyperplasia 
of immunoblasts and plasma ceils occurred between the 4th and  10th postin- 
jection day, accompanied by a gradual increase in spleen weight (Fig.  lb). This 
had begun to recede at 2 wk postinjection. 
Peyer's patch: No lymphoid depletion was seen after ALS. However, many 
necrotic lymphocytes could be seen within small vessels at 24 and 48 hr after a 
single dose of ALS (Fig.  8). 
Bone marrow: Neither ALS- nor NRS-treated animals showed any consistent 
change from the usual predominance of myeloid cells. No definite decrease in 
marrow small lymphocytes was detected in either group. 
Thymus: A drop of 10-15 % in thymus weight was occasionally noted 4 days 
or more after a  single  dose of ALS; no other abnormalities in either thymic 
architecture or cellularity were noted after a single dose of ALS or NRS. In the 
ALS-treated  animals,  the  thymus  appeared  normal  despite  striking  small 
lymphocyte depletion in other organs (Fig. 9). 
Li~er, lungs,  adrenals,  heart, kidneys,  and  brain were  iudged  grossly and 
microscopically normal after either ALS or NRS. 
Effects of a Short Course of ALS or NRS.-- 
Hematologic changes: Anemia usually had corrected itself by one or 2 wk after 
the last dose of  a  course  of  antiserum,  whether  the  course consisted  of  1, 
2, or 3 doses of 0.5 ml. Likewise, lymphocyte counts had reached normal levels 
by 4 wk after the last injection, whether one, two or three doses of ALS were 
given initially (Fig. 2). Occasionally,  large transitional lymphocytes with baso- 
philic cytoplasm could be seen in peripheral blood smears from either ALS- or 
NRS-treated animals.  No platelet abnormalities were  seen  in  either  group. 
Lymph nodes: Paracortical depletion, noted after a single close of ALS, was 
well established 24 hr after the last of three doses of ALS; it tended to persist 
for longer periods, being noticeable 2 wk or more after the last dose. 
Lymph nodes were grossly enlarged after a  short course of either ALS or 
NRS, because of intense medullary hyperplasia and germinal center formation. 
The  greatly  expanded  medulla  tended  to  encroach  upon  and  obscure  the 1286  HETEROLOGOUS  ANTILYMI~HOCYTE SERUM 
boundaries of the paracortical region, so that ALS-induced lymphoid depletion 
could often not be detected in routine hematoxylin and eosin-stained material. 
Lymphoid depletion could be easily discerned,  however, in sections stained with 
methyl green-pyronine. 
Spleen: Mter three doses of ALS,  the spleen showed striking  depletion of 
small lymphocytes from the periarteriolar regions of all lymphoid follicles; this 
persisted longer than 2 wk (Fig.  10). In this markedly depleted area,  a rim of 
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FIG. 2.  Recovery of lymphocyte levels after one, two, or three doses of 0.5 ml ALS given at 
2-day intervals. Each point represents the mean of determinations of lymphocyte count of 
3 or 4 animals. Recovery to initial lymphocyte levels was not complete until 4-5 wk after injec- 
tion, whether one, two, or three doses had been given. 
immunoblasts could be made out surrounding the central arteriole (Fig.  11). 
No such lesions were observed in NRS-treated animals. 
The spleens from both ALS- and NRS-treated animals were enlarged,  with 
generalized  follicular hyperplasia with immunoblasts and plasma cells within 
and at the edge of follicles. Moderate erythroid hyperplasia of the red pulp was 
present, more intense in the ALS-treated animals. 
Bone marrow: Mter three doses of ALS, moderate erythroid hyperplasia was 
usually seen in marrow sections and smears.  Small lymphocytes were present, 
although their numbers were somewhat reduced. NRS-treated animals  showed 
no changes  in the bone marrow. 
The thymus, adrenals,  kidneys, liver, lungs,  and heart were all morphologically ROBERT  N.  TAUB  AND  EUGENE  M.  LANCE  1287 
within normal limits. The absence of either thymic or adrenal atrophy in these 
animals seems noteworthy. 
Skin grafts: The evolution of the homograft reaction was studied in animals 
that received 0.5 ml of ALS 2 and 5 days after being grafted with A strain tail 
skin. 
In both normal and ALS-treated animals,  infiltration of the graft bed with 
lymphocytes and plasma cells was noticeable by the 5th day after grafting.  In 
untreated animals,  this increased until by day -{-10 the graft was edematous 
and heavily infiltrated,  and showed degeneration of dermal appendage  struc- 
tures; epidermal necrosis invariably occurred by day +12 (Fig.  12). 
In  the ALS-treated animals,  the infiltrate  was very sparse,  and failed to 
evolve with the characteristic intensity or perifollicular  distribution seen in the 
usual homograft response. By day 10, only a few lymphocytes and plasma cells 
were present throughout the basal layers of the dermis, with little tendency to 
aggregate around hair follicles. Grafts examined at the 14th  day (3 days after 
the median rejection time in untreated recipients)  appeared  grossly normal, 
with intact epidermis and no induration.  Microscopically, the infiltrate  had 
receded (Fig.  13).  Grafts which rejected after 20 to 25 days showed a  rapid 
and heavy accumulation of mononuclear cells in all layers of the dermis and 
surrounding hair follicles. 
Effects of Chronic Treatment with ALS or NRS.--Mice treated for 3-6 months 
with weekly maintenance doses of ALS or NRS maintained a weight of 26-30 g, 
and showed no evidence of wasting, overt infections,  or tumor formation. This 
regimen of ALS treatment prolonged (180 days or longer)  the survival of skin 
homografts as long as it was continued (16). Deaths in the chronic treatment 
group sometimes occurred within a few hours after a serum injection, presum- 
ably due to anaphylaxis.  After 3 months  of treatment,  additional mortality 
was noted and attributed to renal disease (see below under Kidney) (Table I). 
Hematologic ,ffects:  Anemia was present in  all  animals  treated  with  ALS 
throughout the period of treatment; hematocrits generally remained stable at 
25-30 %. Lymphopenia was a constant feature with lymphocyte values stabi- 
lizing at about one-half  the normal absolute value; recovery time of the normal 
lymphocyte number was delayed for at least 1 month after ALS was  discon- 
tinued. Platelets were present in all blood smears examined; no bleeding tend- 
encies were noted. 
Lymph nodes: Striking paracortical depletion was uniformly present in ALS- 
treated animals after discontinuing ALS; significant  depletion was present as 
long as 1 month later. The cortex appeared intact;  as a rule,  well-developed 
germinal  centers were noted. Some lymph nodes showed loci of cortical fibrosis 
after prolonged treatment. 
In animals  treated chronically with either ALS or NRS, there was striking 1288  HETEROLOGOUS ANTILYMPHOCYTE SERUM 
medullary hyperplasia with sheets of plasma cells and many eosinophils over- 
running  the medullary sinusoids. 
The bone marrow showed marked to moderate erythroid hyperplasia through- 
out the period of chronic ALS treatment. 
The  thymus  was  histologically normal  after 6  months  of  treatment  with 
either ALS or NRS. Thymic cortical depletion was noted in several animals who 
TABLE I 
Some Effects of Prolonged Chronic Administration  of 0.5 ml Weekly of Whole Rabbit Anti-Mouse 
Lymphocyte Serum  (ALS) or Normal Rabbit Serum  (NRS) 
Treatment 
ALS, 0.5 ml per wk 
subcutaneously 
NRS, 0.5 ml per wk 
subcutaneously 









ALS-treated  anlmals  maintained  moderate  lymphopenia  and  splenomegaly rdative  to 
NRS-treated  8nimals.  Both  groups  eventually developed  a  wasting syndrome  with  renal 
lesions (see text). 
developed severe renal disease as a result of treatment with either ALS or NRS. 
The liver, lungs, keart, adrenals, and brain were all within normal histological 
limits in both ALS- and NRS-treated groups. 
Skin grafts were tolerated for prolonged periods in the ALS-treated  group. 
These showed findings similar to those described after a short course of ALS. 
With  continued  treatment,  most  grafts  showed  no  microscopic evidence of 
infiltration at  all  after 3  months of treatment.  The lymph node  draining  a 
viable graft at the end of 8 wk of chronic ALS treatment showed a  combination 
of marked germinal center formation and moderate paracortical depletion; in ROBERT  N.  TAUB  AND  EUGENE  M.  LANCE  1289 
some cases the demarcation d  the paracortical areas was obscured by hyper- 
plasia of the adjacent medullary region (Fig.  14). 
Kidneys: After 3 months of weekly treatment with 0.25 ml of either ALS or 
NRS, most animals developed histologlc evidence of nephritis, with fibrinoid 
accumulations within glomeruli and thickening of Bowman's capsule,  similar 
to lesions seen in serum sickness nephritis (Fig. 15). Immunofluorescent stains 
were negative for rabbit g~mma globulin,  but markedly positive for mouse 
gamma globulin, tending to confirm this impression. The nephritic changes in 
many animals seemed sufficiently advanced to account for the constitutional 
effects of wasting, ascites, pleural effusion, and death seen in a portion of animals 
treated with either ALS or NRS. 
Effects of the Purified Gamma Globulin (IgG) Fraction of ALS or NRS.--The 
histological  effects of a single dose of ALS IgG were entirely similar to those 
produced by whole antiserum. Lymphopenia was observed after 6  hr,  and 
marked paracortical depletion after 48 hr. By 6 days, there was some depletion 
of the paracortical areas and vigorous medullary hyperplasia. 
Animals given a single dose of NRS IgG developed neither lymphopenia nor 
lymphoid depletion, but did develop moderate medullary hyperplasia. 
To determine if the depletion of lymphocytes observed after ALS was related 
to the immunogenicity  of ALS IgG (19), a single dose of ALS IgG was admin- 
istered to recipients 3 wk after they had received a dose of NRS IgG sufficient 
to induce paralysis. In these animals, lymphoid depletion proceeded as in non- 
paralyzed recipients.  However, less medullary hyperplasia was seen in these 
animals than in animals given ALS IgG without prior paralysis. 
Toxic Effects  of Antisera Manufactured  Using Adjuvants.--Some  antisera 
were prepared by inoculating donor rabbits with suspensions of routine thymo- 
cytes incorporated into adjuvants such as aluminium phosphate or Arquad-2- 
HT (15). These antisera were highly toxic to recipient mice and required ex- 
tensive absorption with both  red ceils and minced tissues  before use. Mice 
given 0.5 ml of one such antiserum without previous absorption (serum 33) 
died within 10 days with wasting, hunched posture, and milled fur. 
Numerous pathological lesions were seen in these mice which had no counter- 
part  in  those  animals  given ALS  prepared by our routine method. These 
included: thymic involution with pronounced depletion of cortical thymocytes; 
cortical as well as paracortical depletion of lymphocytes from lymph nodes; 
extreme erythroid hyperplasia with four4old splenomegaly and hepatic foci of 
extramedullary hematopoiesis;  and numerous 0.2-0.5 mm liver microabscesses 
(Fig.  16). 
Histologic Effects of Miscdlaneou~ Antisera.-- 
Horse anti--mouse lympkocyte globulin: Lymph nodes from recipients of this 
immunosuppressively weak antiserum showed mild to moderate paracortical 1290  H~TEROLOGOUS  ANTILYM;PHOCYTE  SERU~ 
depletion of lymphocytes 48 hr after injection, less pronounced than in animals 
treated with routine rabbit ALS. By the 6th day after injection, there was in- 
tense medullary hyperplasia which completely obscured the boundaries of the 
paracortical areas. 
Duck  anti-mouse lymphocyte serum: This  antiserum,  which was completely 
ineffective as an immunosuppressant, produced no lymphoid depletion at any 
time after a single dose. By the 6th postinjection day, some hyperplasia of the 
medulla was in evidence. 
Toxic Effects of High Dose Intravenous ALS.--50 % of recipients  given 1.0 ml 
whole unabsorbed ALS by intravenous injection succumbed within 48 hr. At 
the time of death,  all animals  showed hemoglobinemia and  hemoglobinuria; 
there was massive hemorrhage from the gastrointestinal tract. Obvious infarcts 
were present in liver, kidneys, and lungs. Lymphoid fisses showed paracortical 
and perifoUicular depletion, although the thymus did not appear significantly 
affected. 
DISCUSSION 
In order to classify better the histological  changes  which develop after ALS 
treatment, it is convenient to regard the whole unabsorbed antiserum as a mix- 
ture of three categories of substances (a, b, c) : (a) consists only of that fraction 
of ALS which is immunosuppressively active, contained within the small frac- 
tion  (3-5 %)  of ALS IgG molecules directed specifically  against lymphocyte 
antigens (17, 32, 33); (b) consists  of other rabbit anti-mouse antibodies, either 
IgG or IgM, irrelevant to the immtmosuppressive activity of ALS, but potenti- 
ally or actively toxic to the mouse; and (c) is a category to which we may assign 
all  other rabbit serum components, non-gamma  globulins  as well as gamma 
glob-lln~, which may be immunogenic in mice. 
Each category of substances gives rise to a distinctive histologic  picture; un- 
der the usual  conditions of ALS  administration  all  three  types of histolog- 
ical changes could occur simultaneously. 
Lesions Due to the Immunosuppressive Fraction of ALS.--A consistent pattern 
of histologic  changes was specifically  associated with the immunosuppressive 
capacity of antilymphocytic antiserum.  This consisted of peripheral lympho- 
penia occurring at 48 hr after the first injection of antiserum, selective depletion 
of small lymphocytes from lymph nodes, paracortical  areas and splenic  follic- 
ular periarteriolar regions, and relative preservation of thymic architecture. All 
animals bearing skin grafts under the aegis of ALS, whether for 20 or 150 days, 
showed signs of paracortical and periarteriolar lymphocyte depletion; antisera 
which  were weakly immunosuppressive,  such  as  HALGG,  showed a  lesser 
depletive effect. Duck anti-mouse antiserum,  totally ineffective  at prolonging 
skin  homografts  (15)  seemed incapable  of producing  such  depletion.  Other 
histologic  features of ALS administration  discussed more fully below, such as ROBERT  N. TAUB  AND  EUGENE  3~. LANCE  1291 
hemolytic anemia or hyperplasia of lymphoid organs, seemed irrelevant to the 
immunosuppressive effect and could occur in its absence. 
Lymph node changes similar to those we have observed have been described 
previously by other workers (27, 31), and we concur with them in suggesting 
that this depletion is one characteristic accompaniment of immunosuppression 
of transplantation immunity by antilymphocyte serum. Although extensive 
depletion of the cortical as well as the paracortical area has been achieved with 
intensive treatment with ALS (8) it appears from our studies that paracortical 
depletion alone is sufficient to procure indefinitely prolonged immunosuppres- 
sion. 
It seems likely that a rapid depletion of lymphocytes is brought about by the 
lymphocytotoxic action of ALS; the large numbers of pyknotic nuclei which 
quickly accumulate in lymphoid tissue capillaries  after a single dose of ALS, 
attest to this.  Other evidence obtained from in vivo studies of Cr-51-1abeled 
lymphocytes (30) have established that a single dose of antiserum can destroy 
a large proportion of such lymphocytes in the recipient. 
The restriction of lymphoid tissue depletion to the paracortical and periarter- 
iolar zones is indicative of a preferential action of ALS on the rapidly recirculat- 
ing lymphocyte  pool. These zones, which consist largely of long-lived recirculat- 
ing cells, can be selectively  depleted after maneuvers such as prolonged thoracic 
duct cannulation (22), extracorporeal irradiation of the blood (4), and neonatal 
thymectomy (26). 
Levey and Medawar (21) suggested  that ALS acts in the first instance on 
peripheral lymphocytes. Our previous observations (30) on the distribution of 
radioactively-labeled lymphocytes in  ALS-treated recipients indicated  that 
ALS removed lymphocytes from that portion of the rapidly recirculating pool 
of cells that is external to lymph nodes, and that labeled lymphocytes which 
had already "homed" to lymphoid organs were relatively impervious to the 
action of ALS. In further support of this view, we have determined by radio- 
autographic studies of lymphoid tissues  of ALS-treated mice peffused with 
intravenous tritiated thymidine, that ALS treatment results in a selective and 
extensive removal of long-lived small lymphocytes  from lymph node paracortical 
areas (29). Moreover, it has been determined that fluorescein-labeled antilym- 
phocyte globulin penetrated lymphoid tissues poorly (5). 
The thymus appeared histologically normal in the vast majority of animals 
given repeated doses of routine ALS. It seems unlikely that a direct effect on 
either thymocytes or thymic "humoral factor" is operative in producing the 
specific histologic accompaniments of immunosuppression by ALS. This  does 
not exclude that a portion of the immunosuppressive action of ALS may be 
mediated through the thymus, as has been suggested by some workers (27, 28). 
The fact that the characteristic lesions are found in those areas of lymphoid 
tissue  designated as "thymus-dependent" (26) implies  to  us only that  these 1292  HETEROLOGOUS  ANTI:LYMPHOCYTE  SERUM 
areas reflect the state of the total recirculating lymphocyte compartment with 
which they are in equilibrium. 
The histological course of skin allograft rejection under ALS treatment is of 
interest. The tendency of lymphoid infiltration to decrease and finally disappear 
after chronic, prolonged treatment may herald a state resembling specific  toler- 
ance in a portion of chronically treated, skin-allografted animals. Recent obser- 
vations have indicated that ALS treatment when combined with thymectomy 
(24) or administration of additional antigen  1 may predispose to the acquisition 
of specific  immunological tolerance. 
Lesions Due to "Irrdevant" Antibodies.--Medawar  (23) has pointed out that 
ALS must consist of a mixture of antibodies directed against numerous cellular 
antigens, most of which are irrelevant to its desired immunosuppressive activ- 
ity. Among the identified but irrelevant antibodies which may be  generated 
concomitantly with ALS are included 7S and 19S hemagglutinins and hemoly- 
sins (1),  19S  anti-leukocyte activity (13),  and  anti-mouse  gamma  globulins 
(8); none of these has the capacity to prolong skin allograft survival. 
It is surprising that more in the way of side effects due to irrelevant antibodies 
did not occur in our experimental animals. The most prominent toxic effect 
produced was that of hemolytic anemia, in severe instances accompanied by 
hemoglobinemia and hemoglobinuria. Bone marrow and splenic erythroid hy- 
perplasia occurred after treatment even with ALS that had been absorbed with 
red  cells,  although no  anemia  developed, making  it  likely  that  even  ab- 
sorbed ALS possesses  some, albeit controllable anti-red cell activity. 
Antisera  manufactured with  the  use  of aluminium phosphate  or Arquar 
incorporated  into  the  immunizing cell  suspensions  were  considerably more 
toxic than routinely prepared sera, and it is possible that adjuvant immuniza- 
tion increased  the  amount of irrelevant antibodies  present.  Apart  from an 
intense hemolytic anemia, accompanied by extreme erythroid metaplasia in the 
spleen, marrow, and even the liver, widespread and variegated lesions were 
seen in other organs: 
The thymus was usually depleted of cortical lymphocytes after two injections 
of such antiserum. Denman and Frenkel (5)  and Lance (17) have determined 
that ALS does not enter the thymus to any appreciable extent. It thus seems 
likely to us that this depletion is brought about by a generalized stress response 
rather than by any direct effect of ALS on thymic tissue. The generalized lymph 
node depletion seen in these mice also reflects a process qualitatively different 
from that obtaining with our usual antisera, and one that is unnecessary for 
allograft prolongation. 
The punctate lesions seen in the liver of these animals may represent invasion 
of pathogens as a result of lowered host resistance, as in the HMV infections 
1  Lance, E. M., and P. B. Medawar. Data to be published, ROBERT  N. TAUB  AND  EUGENE  M. LANCE  1293 
described in thymectomized mice (6). We have not, however, excluded that  they 
are due to a directly toxic effect of the antiserum on liver tissue. 
The  administration  of large  intravenous  doses of routine  ALS  results  in 
marked  damage  to erythrocytes and  platelets,  and widespread hemorrhages 
and infarction in many organs. It seems possible that irrelevant and potentially 
toxic antibodies are usually present in even our routine  antiserum,  but are 
absorbed onto tissue receptor sites when the antiserum is injected subcutane- 
ously. 
Lesions  Due  to  Immunization  by  Immunogenic Components of ALS.--In 
anlmais  given either  ALS or NRS,  the  histologic  features of immunization 
develop. These  consist of hypertrophy of lymphoid tissue with pronounced 
medullary hyperplasia  and  germinal  center formation  in  lymph nodes,  and 
follicular hyperplasia in spleens. Blast forms and plasma cells are prominent in 
these regions.  In some animals,  eosinophilia  in peripheral  blood and lymph 
nodes may develop as in genuine serum sickness. 
The medullary hyperplasia which occurs in lymph nodes during the period 
when cellular hypersensitivity has been virtually abolished by ALS treatment is 
of particular interest. It confirms  the unique capacity of ALS to discriminate 
between humoral and cellular  responses,  and selectively to suppress the latter, 
as noted by Lance and Batchelor (18). It also provides additional evidence that 
the suppressive effects of ALS are exerted preferentially on that population of 
cells which mediates cellular  immunity.  Although several investigators have 
noted the ability of ALS to transform lymphocytes to immunoblasts in vitro 
(7, 9, 11, 33), there is little in our studies to suggest that lymphocyte activation 
by means other than antigenic stimulation takes place in vivo. Medullary pro- 
liferation  with  blast  transformation  takes place slightly more vigorously in 
ALS than NRS-treated animals,  doubtless due to the greater immunogenicity 
of ALS IgG (19). Previous immunization of animals with N-RS IgG can mark- 
edly augment this transformation,  while prior paralysis to NRS IgG can sig- 
nificantly inhibit it. It thus seems that these changes are due to an orthodox 
~mmune response to rabbit serum constituents,  and are not directly relevant 
to the immunosuppressive action of ALS. 
In chronically treated animals,  "complex" nephritis may develop as a result 
of hyperimmunlzation to rabbit serum components. Similar  lesions have been 
noted by others in other species  (10,  12). Lance and Dresser's finding  that 
paralysis  of ALS recipients with NRS IgG abolishes a  subsequent  immune 
response to purified ALS gamma G (19) may provide a means for circumventing 
this hazard. Our present findings in animals tolerant of NRS IgG would support 
this consideration. 
SD'M-~r~RY 
The effects of heterologous rabbit anti-mouse lymphocyte antiserum on the 
morphology of lymphoid  and  other  tissues was investigated  in  CBA mice. 1294  HETEROLOGOUS  ANT]LYMPHOCYTE  SERU'~ 
The lymphoid tissues exhibited characteristic changes specific for ALS treat- 
ment,  which  were  an  invariable  accompaniment  to  its  immunosuppressive 
effects.  These  consisted  of  peripheral  lymphopenia  occurring  at  some  time 
during a course of ALS treatment and persistent depletion of small lymphocytes 
in lymph node paracortical areas and splenic follicular periarteriolar zones. The 
thymic histology was generally weU preserved. 
It is suggested that the relevant lesions reflect a rapid depletion of the pool 
of recirculating lymphocytes, possibly by a primary cytotoxic effect exerted on 
cells peripheral to lymphoid tissue. 
Other  histologic  features  attendant  to  the  administration  of  ALS  were 
accounted for as  consequences  of immunization  of ALS  recipients  to rabbit 
serum constituents or by the deleterious effects of antibodies directed against 
tissues other than lymphoid cells. 
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FIG. 3. Brachial lymph node of CBA mouse 48 hr after a single injection of 0.5 ml 
rabbit anit-mouse lymphocyte serum.  There  is  striking  depletion  of lymphocytes 
from the paracorfical areas, with relative sparing of the cortical and primary follicular 
zones. Methyl green-pyronine.  X  52. 
FIG. 4. Brachial lymph node 48 hr after a single dose of normal rabbit serum. The 
paracortical areas show no significant  depletion.  Methyl green-pyronine.  X  52. 1297 ~.~ "~ 
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FIG. 6. Brachial lymph node 8 days after injection of normal rabbit serum. Note 
the enlargement and medullary hypertrophy as in Fig. 5 However,  the paracortical 
areas  show  neither depletion nor infiltration by medullary cells.  Hematoxylin and 
eosin.  ×  52. 
FIG. 7. Axillary lymph node 24 hr after a  single subcutaneous dose  of ALS. Note 
cellular debris and pyknotic nuclei within small vessels in the cortical and paracortieal 
areas. There is a striking reduction in numbers of small lymphocytes, the cells in the 
paracortical areas,  leaving mostly large lymphocytes, immunobtasts, and reticulum 
cells.  Methyl green--pyronine. ×  256. 
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FIG. 8. Intestinal  Peyer's patch  48  hr  after  a  single  dose  of  ALS.  Only  minimal 
lymphocyte  depletion  is present.  However,  many  necrotic  cells  can  be  seen  within 
small  vessels.  Methyl  green-pyronine.  ×  132. 
FIG. 9. Thymus 4  days  after  a  single  dose of  ALS.  No  consistent abnormality  in 
either  thymic  architecture  or  cellularity  is  noted.  Hematoxylin  and  eosin.  ×  132. 1302  HETEROLOGOUS ANTILYMPHOCYTE SERUM 
FIG. 11. Higher power  view  of  p~riarteriolar region.  Note  the persistence of  im- 
munoblasts surrounding the  central arteriole.  ×  640. 
FIG. 12. A  strain tail  skin homograft on  CBA  recipient,  12  days after grafting. 
There is edema,  heavy mononuclear infiltration, and epidermal necrosis,  typical of 
graft rejection. Hematoxylin and eosin.  ×  96. 1303 1304  I-YETEROLOGOUS ANT~YMPHOCYTE  SERUNI 
FIG. 13. A strain graft on CBA recipient that received 0.5 ml ALS on the 2nd and 
5th days after grafting. 13 days after grafting, the epidermis is intact with no edema 
and minimal infiltrate. Hematoxylin and eosin.  X  96. 
Fio. 14. Axillary lymph node draining a viable A strain skin allograft after 8 wk 
of chronic ALS treatment. Note paracortical depletion, somewhat obscured in outline 
by hyperplasia of  adjacent medullary tissue.  Note  formation of  germinal centers. 
Hematoxylin and eosin.  ×  52. 1305 1306  }]ETEROLOGOUS ANTILYMPHOCYTE SERUM 
FIG. 15.  Glomerular alterations seen as a  result of either ALS or NRS given twice 
weekly for 3 months. There is a thickening of Bowman's capsule and fibrinoid deposition 
within glomerular  capillaries.  The insert shows  an  immunofluorescent  stain  demon- 
strating the presence of  mouse gamma globulin within the fibrinoid deposits.  Hema- 
toxylin and eosin.  X  291. 
FIG.  16.  Focal hepatic necrosis with microabscess formation produced  by a  single 
dose  of  adjunct  antiserum.  Hematoxylin and  eosin.  X  256. 1307 